(Q36527739)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822222%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

The performance of nanocarriers for transmucosal drug delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822222%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822222%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Marcos Garcia-Fuentes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822222%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

María J. Alonso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822222%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Noémi Csaba

1

1 reference

14 August 2017

Marcos Garcia-Fuentes

2

1 reference

14 August 2017

María José Alonso

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822222%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Delivery

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822222%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822222%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822222%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

463-478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822222%20AND%20SRC:MED&resulttype=core&format=json

The rise and rise of drug delivery

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Principles of transmucosal delivery of therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Issues in oral nanoparticle drug carrier uptake and targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Transmucosal macromolecular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Mucoadhesive nanoparticulate systems for peptide drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Colloidal drug carriers: achievements and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Polysaccharide colloidal particles as delivery systems for macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Small-scale systems for in vivo drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Comparison of the effects of potential parenteral vehicles for poorly water soluble anticancer drugs (organic cosolvents and cyclodextrin solutions) on cultured endothelial cells (HUV-EC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Nanosuspensions in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Formulation and characterization of triclosan sub-micron emulsions and nanocapsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

The potential of chitosan for the oral administration of peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Enhancement of nasal absorption of insulin using chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Design of biodegradable particles for protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

PLGA nanoparticles in drug delivery: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

The role of branched polyesters and their modifications in the development of modern drug delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

PLA-PEG particles as nasal protein carriers: the influence of the particle size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Formulation and surface modification of poly(ester-anhydride) micro- and nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Poly(ester-anhydride):poly(beta-amino ester) micro- and nanospheres: DNA encapsulation and cellular transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

pH-Sensitive hydrogels as gastrointestinal tract absorption enhancers: transport mechanisms of salmon calcitonin and other model molecules using the Caco-2 cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Physicochemical behavior and cytotoxic effects of p(methacrylic acid-g-ethylene glycol) nanospheres for oral delivery of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Biologically erodable microspheres as potential oral drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Salmonella-like bioadhesive nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

The potential of chitosan in ocular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Ocular drug delivery of progesterone using nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Therapeutic manipulation of the immune system: enhancement of innate and adaptive mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Technologies to improve immunisation safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

The biopharmaceutical aspects of nasal mucoadhesive drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Phagocytosis: elegant complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Nanoparticles as carriers for nasal vaccine delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Formulation aspects of biodegradable polymeric microspheres for antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Pulmonary DNA vaccination: concepts, possibilities and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Intranasal immunization against influenza virus using polymeric particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Design of amine-modified graft polyesters for effective gene delivery using DNA-loaded nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Transport of polymeric nanoparticle gene carriers in gastric mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.463

21 January 2018

Identifiers

DOI

10.1517/17425247.3.4.463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822222%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference